
==== Front
Cancer Cell Int
Cancer Cell Int
Cancer Cell International
1475-2867
BioMed Central London

3311
10.1186/s12935-024-03311-7
Correction
Correction: 4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis
Li Wei 1
Huang Bai-Sheng 1
Xiong Yuan-Yuan 2
Yang Li-Jian 3
http://orcid.org/0000-0003-0571-454X
Wu Li-Xiang ywlx@mail.csu.edu.cn

1
1 https://ror.org/00f1zfq44 grid.216417.7 0000 0001 0379 7164 Department of Physiology, School of Basic Medical Sciences, Central South University, 110 Xiangya Road, Changsha City, Hunan Province China
2 https://ror.org/01nxv5c88 grid.412455.3 0000 0004 1756 5980 Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China
3 https://ror.org/01sy5t684 grid.508008.5 0000 0004 4910 8370 Department of Neurosurgery, The First Hospital of Changsha, Changsha, China
14 9 2024
14 9 2024
2024
24 31726 3 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcCorrection to: Cancer Cell International (2022) 22:32 10.1186/s12935-021-02434-5

In this article [1], the WB band for mTOR in Fig. 3B and the Control group of T98G cells in Fig. 4A were incorrect. The corrected Figs. 3 and 4 are given below.Fig. 3 4, 5-Dimethoxycanthin-6-one inhibits the AKT/mTOR and MAPK signaling pathways. A 4, 5-Dimethoxycanthin-6-one inhibition of the AKT/mTOR and MAPK signaling pathways in U251 cells. B 4, 5-Dimethoxycanthin-6-one inhibition of the AKT/mTOR and MAPK signaling pathways in T98G cells. *P < 0.05 compared with the Control group

Fig. 4 4, 5-Dimethoxycanthin-6-one inhibits cell proliferation. A Cell proliferation detected using the EDU assay. B The migration distance of cells was measured using a wound scratch assay. C Colon numbers were analyzed using a colony formation assay. *P < 0.05 compared with the Control group

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
Reference

1. Li W Huang BS Xiong YY Yang LJ Wu LX 4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis Cancer Cell Int 2022 22 32 10.1186/s12935-021-02434-5 35042538
Li W, Huang BS, Xiong YY, Yang LJ, Wu LX. 4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis. Cancer Cell Int. 2022;22:32. 10.1186/s12935-021-02434-5.35042538 10.1186/s12935-021-02434-5
